Chronic hyperglycemia impairs functional vasodilation via increasing thromboxane-receptor-mediated vasoconstriction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 1, 2007, Pages

  Xiang, Lusha ^a   Naik, Jay S ^a   Abram, Sean R ^a   Hester, Robert L ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Arachidonic acid; Diabetes; Prostacyclin

Indexed keywords

GLUCOSE; INSULIN; MANNITOL; STREPTOZOCIN; THROMBOXANE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MALE; MUSCLE EXCITATION; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; VASODILATATION;

ANIMALS; CHRONIC DISEASE; HYPERGLYCEMIA; MALE; RATS; RATS, ZUCKER; RECEPTORS, THROMBOXANE; STREPTOZOCIN; VASOCONSTRICTION; VASODILATION;

EID: 33846186858     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00623.2006     Document Type: Article

References (38)

1. Alonso C, Proto M, Coviello A, Peral de Bruno M. Insulin improves the endothelium-independent relaxation and the contractile response in aorta from hypertensive diabetic rats. Cell Mol Biol (Noisy-le-grand) 51: 565-572, 2005.
2. Amore A, Cirina P, Mitola S, Peruzzi L, Gianoglio B, Rabbone I, Sacchetti C, Cerutti F, Grillo C, Coppo R. Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. Kidney Int 51: 27-35, 1997.
3. Bagi Z, Erdei N, Toth A, Li W, Hintze TH, Koller A, Kaley G. Type 2 diabetic mice have increased arteriolar tone and blood pressure: enhanced release of COX-2-derived constrictor prostaglandins. Arterioscler Thromb Vasc Biol 25: 1610-1616, 2005.
4. Beckman JA, Goldfine AB, Gordon MB, Creager MA. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 103: 1618-1623, 2001.
5. Bohlen HG, Nase GP. Arteriolar nitric oxide concentration is decreased during hyperglycemia-induced βII PKC activation. Am J Physiol Heart Circ Physiol 280: H621-H627, 2001.
6. Bohlen HG, Nase GP, Jin JS. Multiple mechanisms of early hyperglycaemic injury of the rat intestinal microcirculation. Clin Exp Pharmacol Physiol 29: 138-142, 2002.
7. Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, Kouroedov A, Delli Gatti C, Joch H, Volpe M, Luscher TF. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 107: 1017-1023, 2003.
8. Cosentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 32, Suppl 3: S54-S61, 1998.
9. Dai FX, Diederich A, Skopec J, Diederich D. Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals. J Am Soc Nephrol 4: 1327-1336, 1993.
10. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267, 1996.
11. Hammer LW, Ligon AL, Hester RL. Differential inhibition of functional dilation of small arterioles by indomethacin and glibenclamide. Hypertension 37: 599-603, 2001.
12. Higashi Y, Sasaki S, Nakagawa K, Kimura M, Noma K, Sasaki S, Hara K, Matsuura H, Goto C, Oshima T, Chayama K, Yoshizumi M. Low body mass index is a risk factor for impaired endothelium-dependent vasodilation in humans: role of nitric oxide and oxidative stress. J Am Coll Cardiol 42: 256-263, 2003.
13. Hishinuma T, Tsukamoto H, Suzuki K, Mizugaki M. Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. Prostaglandins Leukot Essent Fatty Acids 65: 191-196, 2001.
14. Hoedemaekers CW, Pickkers P, Netea MG, van Deuren M, Van der Hoeven JG. Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial (ISRCTN95608630). Crit Care Clin 9: R790-R797, 2005.
15. Hoshiyama M, Li B, Yao J, Harada T, Morioka T, Oite T. Effect of high glucose on nitric oxide production and endothelial nitric oxide synthase protein expression in human glomerular endothelial cells. Nephron Exp Nephrol 95: e62-e68, 2003.
16. Hudson BI, Wendt T, Bucciarelli LG, Rong LL, Naka Y, Yan SF, Schmidt AM. Diabetic vascular disease: it's all the RAGE. Antioxid Redox Signal 7: 1588-1600, 2005.
17. 2) levels during incremental dynamic exercise in humans determined by in vivo microdialysis. Prostaglandins Leukot Essent Fatty Acids 64: 259-263, 2001.
18. Kim SH, Park KW, Kim YS, Oh S, Chae IH, Kim HS, Kim CH. Effects of acute hyperglycemia on endothelium-dependent vasodilation in patients with diabetes mellitus or impaired glucose metabolism. Endothelium 10: 65-70, 2003.
19. + channels in human omental artery. Arterioscler Thromb Vasc Biol 24: 2290-2295, 2004.
20. Lash JM, Nase GP, Bohlen HG. Acute hyperglycemia depresses arteriolar NO formation in skeletal muscle. Am J Physiol Heart Circ Physiol 277: H1513-H1520, 1999.
21. 2 plasma levels and some other biochemical parameters during the initiation and development of non-insulin-dependent diabetes mellitus (NIDDM) syndrome in the rabbit. Prostaglandins Leukot Essent Fatty Acids 62: 285-291, 2000.
22. Lee IK, Kim HS, Bae JH. Endothelial dysfunction: its relationship with acute hyperglycemia and hyperlipidemia. Int J Clin Pract Suppl 129: 59-64, 2002.
23. 2 production of peritoneal macrophages in diabetic rats. J Surg Res 125: 121-127, 2005.
24. Mayhan WG. Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus. Am J Physiol Heart Circ Physiol 256: H621-H625, 1989.
25. Mayhan WG, Simmons LK, Sharpe GM. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am J Physiol Heart Circ Physiol 260: H319-H326, 1991.
26. McKay MK, Gardner AL, Boyd D, Hester RL. Influence of venular prostaglandin release on arteriolar diameter during functional hyperemia. Hypertension 31: 213-217, 1998.
27. 2 attenuates functional hyperemia in the hamster cremaster muscle. Am J Physiol Heart Circ Physiol 276: H1289-H1294, 1999.
28. Peppa M, Vlassara H. Advanced glycation end products and diabetic complications: a general overview. Hormones (Athens Greece) 4: 28-37, 2005.
29. Peredo HA, Feleder EC, Adler-Graschinsky E. Time-course of the alterations in prostanoid production and in contractile responses of mesenteric beds isolated from streptozotocin diabetic rats. Prostaglandins Leukot Essent Fatty Acids 60: 269-274, 1999.
30. Pichler G, Urlesberger B, Jirak P, Zotter H, Reiterer E, Muller W, Borkenstein M. Reduced forearm blood flow in children and adolescents with type 1 diabetes (measured by near-infrared spectroscopy). Diabetes Care 27: 1942-1946, 2004.
31. Quilley J, Chen YJ. Role of COX-2 in the enhanced vasoconstrictor effect of arachidonic acid in the diabetic rat kidney. Hypertension 42: 837-843, 2003.
32. Sugimoto R, Enjoji M, Kohjima M, Tsuruta S, Fukushima M, Iwao M, Sonta T, Kotoh K, Inoguchi T, Nakamuta M. High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen-activated protein kinase. Liver Int 25: 1018-1026, 2005.
33. Tesfamariam B, Brown ML, Deykin D, Cohen RA. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 85: 929-932, 1990.
34. Vequaud P, Freslon JL. Components of flow-induced dilation in rat perfused coronary artery. Cell Biol Toxicol 12: 227-232, 1996.
35. Wilson JR, Kapoor SC. Contribution of prostaglandins to exercise-induced vasodilation in humans. Am J Physiol Heart Circ Physiol 265: H171-H175, 1993.
36. Xiang L, Naik J, Hester RL. Exercise-induced increase in skeletal muscle vasodilatory responses in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 288: R987-R991, 2005.
37. Xiang L, Naik JS, Hodnett BL, Hester RL. Altered arachidonic acid metabolism impairs functional vasodilation in metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 290: R134-R138, 2006.
38. 2 receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51: 198-203, 2002.